Ud af de 25 patienter med abnormt stor lever ved baseline i gruppen med ugentlig behandling havde 80% (20 patienter) reduktioner i levervolumen til inden for det normale område ved forsøgets afslutning.
Of the 25 patients with abnormally large livers at baseline in the weekly treatment group, 80% (20 patients) had reductions in liver volume to within the normal range by the end of the study.